Xu, Y., Chen, K., Cai, Y., Cheng, C., Zhang, Z., & Xu, G. (2019). Overexpression of Rad51 predicts poor prognosis and silencing of Rad51 increases chemo-sensitivity to doxorubicin in neuroblastoma. Am J Transl Res.

Xu, Yonghu, Kai Chen, Yuanxia Cai, Cheng Cheng, Zihan Zhang, και Guofeng Xu. "Overexpression of Rad51 Predicts Poor Prognosis and Silencing of Rad51 Increases Chemo-sensitivity to Doxorubicin in Neuroblastoma." Am J Transl Res 2019.

Xu, Yonghu, et al. "Overexpression of Rad51 Predicts Poor Prognosis and Silencing of Rad51 Increases Chemo-sensitivity to Doxorubicin in Neuroblastoma." Am J Transl Res 2019.